The Current Ratio as of September 2024 (TTM) for Liquidia Corporation (LQDA) is 6.08

According to Liquidia Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 6.08. This represents a change of -4.30% compared to the average of 6.35 of the last 4 quarters.

Liquidia Corporation (LQDA) Historical Current Ratio (quarterly & annually)

How has LQDA Current Ratio performed in the past?

The mean historical Current Ratio of Liquidia Corporation over the last ten years is 4.85. The current 6.08 Current Ratio has changed 12.43% with respect to the historical average. Over the past ten years (40 quarters), LQDA's Current Ratio was at its highest in in the June 2022 quarter at 15.87. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Liquidia Corporation (LQDA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Liquidia Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Liquidia Corporation (LQDA) Average Current Ratio

How has LQDA Current Ratio performed in the past?

The current Current Ratio of Liquidia Corporation (LQDA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Liquidia Corporation (LQDA) Current Ratio vs. Peers

How is LQDA’s Current Ratio compared to its peers?

Liquidia Corporation’s Current Ratio is greater than BioMarin Pharmaceutical Inc. (3.05), less than Vaxcyte, Inc. (17.88), greater than Legend Biotech Corporation (4.84), greater than Bio-Techne Corporation (3.87), greater than United Therapeutics Corporation (4.35), greater than Geron Corporation (3.61), greater than NRx Pharmaceuticals, Inc. (0.21), greater than Agenus Inc. (0.37), less than Replimune Group, Inc. (13.46), greater than Nuvectis Pharma, Inc. (3.17), greater than Lyra Therapeutics, Inc. (3.60), less than Kronos Bio, Inc. (8.49), less than Gossamer Bio, Inc. (8.21), less than Terns Pharmaceuticals, Inc. (21.02), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Acumen Pharmaceuticals, Inc. (17.37), less than Inozyme Pharma, Inc. (9.84), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Immunocore Holdings plc (5.17), greater than Mirum Pharmaceuticals, Inc. (3.28), less than Larimar Therapeutics, Inc. (10.93), less than KalVista Pharmaceuticals, Inc. (8.55),

Build a custom stock screener for Liquidia Corporation (LQDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liquidia Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Liquidia Corporation (LQDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Liquidia Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.